
Check-Cap Ltd. CHEK
€ 1.15
-1.7%
Geschäftsbericht 2024
hinzugefügt 25.10.2025
Check-Cap Ltd. P/CF 2011-2025 | CHEK
P/CF Jährlich Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.541 | -0.783 | -0.834 | -0.157 | -0.161 | -0.92 | -770 | -1.4 K | -4.17 | -2.75 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.157 | -1.4 K | -218 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | $ 0.33 | -6.23 % | $ 30.6 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | $ 3.75 | 1.08 % | $ 308 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | $ 2.99 | - | $ 399 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | $ 21.99 | - | $ 562 M | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | $ 4.03 | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | $ 0.46 | 0.22 % | $ 16.8 M | ||
|
Meridian Bioscience
VIVO
|
16.4 | $ 33.97 | - | $ 1.49 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | $ 0.48 | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
-5.45 | $ 2.04 | -9.15 % | $ 517 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 28.02 | 3.05 % | $ 20 B | ||
|
Quotient Limited
QTNT
|
-2.36 | $ 0.32 | -11.32 % | $ 1.1 M | ||
|
Quidel Corporation
QDEL
|
18.7 | $ 27.31 | -1.44 % | $ 1.15 B | ||
|
Bioventus
BVS
|
22.9 | $ 7.55 | 15.09 % | $ 473 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | $ 165.21 | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
23.7 | $ 565.36 | 0.07 % | $ 216 B | ||
|
Heska Corporation
HSKA
|
-38.7 | $ 119.99 | - | $ 1.31 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 1.01 | 2.98 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-38.4 | $ 30.23 | -4.24 % | $ 1.75 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | $ 0.17 | -34.28 % | $ 263 K | ||
|
Biocept
BIOC
|
-0.447 | $ 0.43 | -13.05 % | $ 7.29 M | ||
|
Syneos Health
SYNH
|
20.8 | $ 42.98 | - | $ 4.46 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | $ 0.09 | - | $ 21.2 M | ||
|
DermTech
DMTK
|
-0.551 | $ 0.09 | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
1.15 | $ 0.29 | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 31.25 | 20.24 % | $ 868 M | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 13.47 | -1.97 % | $ 382 M | ||
|
PerkinElmer
PKI
|
22.5 | $ 115.24 | -0.91 % | $ 14.7 B | ||
|
OpGen
OPGN
|
-1.87 | $ 1.96 | -16.95 % | $ 1.54 M | ||
|
DexCom
DXCM
|
65.2 | $ 60.96 | 0.88 % | $ 23.5 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | $ 2.12 | -2.3 % | $ 19.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 11.65 | -4.98 % | $ 125 M | ||
|
Danaher Corporation
DHR
|
22.7 | $ 214.35 | 0.12 % | $ 157 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 6.05 | -3.9 % | $ 1.31 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.51 | -6.47 % | $ 5.77 M | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 22.72 | -1.69 % | $ 687 M | ||
|
Psychemedics Corporation
PMD
|
-11.4 | $ 2.67 | -1.84 % | $ 15.3 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | $ 0.77 | - | $ 7.1 B | ||
|
Renalytix AI plc
RNLX
|
-0.754 | $ 0.21 | 5.66 % | $ 22.7 M | ||
|
Myriad Genetics
MYGN
|
-112 | $ 6.56 | -19.8 % | $ 594 M | ||
|
Medpace Holdings
MEDP
|
16.7 | $ 596.89 | 0.48 % | $ 18.5 B | ||
|
IQVIA Holdings
IQV
|
13.1 | $ 211.79 | -1.0 % | $ 38.4 B | ||
|
CareDx, Inc
CDNA
|
-28.3 | $ 14.33 | -3.01 % | $ 770 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 16.72 | -3.8 % | $ 99.4 M | ||
|
Biodesix
BDSX
|
-1.89 | $ 7.52 | 18.53 % | $ 975 M | ||
|
T2 Biosystems
TTOO
|
-0.162 | $ 0.12 | -39.35 % | $ 313 K | ||
|
OPKO Health
OPK
|
-6.62 | $ 1.4 | -0.36 % | $ 972 M | ||
|
Guardant Health
GH
|
-24.4 | $ 98.81 | -0.12 % | $ 12.1 B | ||
|
Agilent Technologies
A
|
28.3 | $ 146.82 | 1.47 % | $ 44.6 B | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 0.39 | -3.37 % | $ 11.4 M | ||
|
Lantheus Holdings
LNTH
|
11.9 | $ 57.99 | 2.06 % | $ 4.01 B |